Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Vasculitis 1Urogenital Neoplasms 1Stroke 1Lung Neoplasms 1Inflammation 1Depressive Disorder, Major 1Depression 1Colitis 1Cognitive Dysfunction 1Carcinoma, Non-Small-Cell Lung 1Aneurysm 1

Interventions

palbociclib 1microcrystalline cellulose 1epigallocatechin gallate 1dapagliflozin 1Vitamin D 1Tablets 1Specimen Handling 1Selenium 1Saline Solution 1Pregabalin 1Platelet Count 1Plastic Surgery Procedures 1Omeprazole 1Losartan 1Ketorolac 1Infliximab 1Immunotherapy, Adoptive 1Dexmedetomidine 1Cognitive Behavioral Therapy 1Calcium 1Bevacizumab 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Inflammation × Infliximab × Clear all
NCT06136546 2025-05-07

Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab

Massachusetts General Hospital

Phase 2 Recruiting
100 enrolled

Depression, Depressive Disorder, Major, Inflammation, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡